Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Salomon A. Stavchansky"'
Publikováno v:
International journal of pharmaceutics. 593
Electronic cigarettes (e-cigs) are devices that aerosolize nicotine-containing liquids for delivery as an inhaled vapor. E-cigs are currently marketed as smoking cessation devices, though the emergence and rapid adoption of these devices in recent ye
Publikováno v:
Gene Regulation and Systems Biology, Vol 11 (2017)
Gene Regulation and Systems Biology
Gene Regulation and Systems Biology
1[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im), a synthetic derivative of oleanolic acid that exhibits antioxidant and anti-inflammatory activity in several animal and in vitro models, has been shown to be beneficial if given afte
Publikováno v:
Biomedical Chromatography. 28:241-246
A validated LCMS method was developed for the quantitative determination of caffeic acid phenethyl amide (CAPA) and caffeic acid phenethyl ester (CAPE) from rat plasma. Separation was achieved using a reverse-phase C12 HPLC column (150 × 2.00 mm, 4
Publikováno v:
Drug Delivery and Translational Research. 2:106-111
A drug delivery system (DDS) consisting of a perforated microtube (polyimide, inside diameter = 1.8 mm, tube length = 20 mm, hole size = 0.15 mm) was characterized in vitro and in vivo for its usefulness for long-term release of hydrophilic drugs at
Publikováno v:
Pharmacology & Pharmacy. :291-294
Continuous delivery of local anesthetics might be useful for management of localized and chronic pain. Controlled release injectable anesthetics have been developed but they can deliver the drug for only few days and the release is not zero-order. A
Publikováno v:
Biomedical Chromatography. 26:594-598
A validated C18 reverse-phase HPLC method with UV detection at 320 nm was developed and used for the stability evaluation of caffeic acid phenethyl amide (CAPA) and caffeic acid phenethyl ester (CAPE) in rat plasma. CAPA is the amide derivative of CA
Autor:
Sabine Kopp, Kamal K. Midha, D. M. Barends, Salomon A Stavchansky, Stefanie Strauch, Jennifer B. Dressman, Ekarat Jantratid, Vinod P. Shah, H. E. Junginger
Publikováno v:
Journal of Pharmaceutical Sciences. 100:2054-2063
Literature data relevant to the decision to allow a waiver of in vivo bioequiva- lence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing lamivudine as the only active pharmaceutical ingredient were reviewed. T
Autor:
Sabine Kopp, Stefanie Strauch, Ekarat Jantratid, D. M. Barends, Kamal K. Midha, H. E. Junginger, Salomon A Stavchansky, Jennifer B. Dressman, Vinod P. Shah
Publikováno v:
Journal of Pharmaceutical Sciences. 100:11-21
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release solid oral dosage forms containing mefloquine hydrochloride as the only active pharmaceutical ingredient (API) are
Autor:
Mei-Ling Chen, Paul Fackler, Russell Katz, Mario L. Rocci, Prabu Nambiar, Lawrence X. Yu, Mehul Mehta, Bertil Abrahamsson, Vinod P. Shah, Gerard Sanderink, Kamal K. Midha, Suneel K. Gupta, Derek A. Ganes, Yaning Wang, Sheldon H. Preskorn, James Caro, Barbara M. Davit, Dale P. Conner, Robert Temple, Helen Winkle, Colm Farrell, Salomon A Stavchansky, Avinash G. Thombre
Publikováno v:
Clinical Therapeutics. 32:1704-1712
Background: Modified-release (MR) products are complex dosage forms designed to release drug in a controlled manner to achieve the desired efficacy and safety profiles. Inappropriate control of drug release from such products may result in reduced ef
Autor:
Zhiquan Luo, Phillip D. Bowman, Zhuojie Wu, Paul S. Ho, Salomon A Stavchansky, Ashish Rastogi
Publikováno v:
Biomedical Microdevices. 12:915-921
A drug delivery system that consists of microperforated polyimide microtubes was developed and characterized. Two groups of polyimide tubes were used. One set consisted of microtubes (I.D. = 125 microm) with 32.9 +/- 1.7 microm size holes. The second